Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
2011-5-9
pubmed:abstractText
AS160 (TBC1D4) is a known Akt substrate that is phosphorylated downstream of insulin action and that leads to regulated traffic of GLUT4. As GLUT4 vesicle fusion with the plasma membrane is a highly regulated step in GLUT4 traffic, we investigated whether AS160 and 14-3-3 interactions are involved in this process. Fusion was inhibited by a human truncated AS160 variant that encompasses the first N-terminal phosphotyrosine-binding (PTB) domain, by either of the two N-terminal PTB domains, and by a tandem construct of both PTB domains of rat AS160. We also found that in vitro GLUT4 vesicle fusion was strongly inhibited by the 14-3-3-quenching inhibitors R18 and fusicoccin. To investigate the mode of interaction of AS160 and 14-3-3, we examined insulin-dependent increases in the levels of these proteins on GLUT4 vesicles. 14-3-3? was enriched on insulin-stimulated vesicles, and its binding to AS160 on GLUT4 vesicles was inhibited by the AS160 tandem PTB domain construct. These data suggest a model for PTB domain action on GLUT4 vesicle fusion in which these constructs inhibit insulin-stimulated 14-3-3? interaction with AS160 rather than AS160 phosphorylation.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-10547847, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-11598141, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-11994271, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-12637568, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-14744259, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-15169906, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-15254270, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-15616009, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-15866888, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-15919790, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-15971998, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-16154100, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-16154996, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-16213228, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-16762977, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-16880201, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-16893906, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-16914513, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-17189206, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-17339344, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-17403373, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-17617058, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-17995453, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-18039703, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-18063571, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-18076383, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-18325908, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-18477703, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-18801932, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-18931681, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-19046570, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-19470471, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-19960480, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-20220755, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-20349035, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-20816091, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-21195350, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-6360220, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-8202531, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-8349666, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-8805370, http://linkedlifedata.com/resource/pubmed/commentcorrection/21454690-9651341
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1083-351X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
13
pubmed:volume
286
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
16574-82
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
AS160 phosphotyrosine-binding domain constructs inhibit insulin-stimulated GLUT4 vesicle fusion with the plasma membrane.
pubmed:affiliation
Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, United Kingdom.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't